Tumor shrinkage to make inoperable tumors become operable for removal, and/or improved quality of life for the patients is what we'll be looking for in the upcoming trial in LAPC.
If either of those events happen, or both, we'll practically be guaranteed FDA approval.
Tumor shrinkage is definitely a game changer, especially when those tumors are made to shrink enough to be removed.